Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >

New Hope for Melanoma

PROGRAM DETAILS:

After many years with no new treatments for Melanoma, the FDA has just approved a breakthrough treatment for the disease.  In this program two leading experts from the Seattle Cancer Care Alliance, Dr. David Byrd and Dr. Kim Margolin, discuss melanoma, clinical trials and this exciting new treatment.  You’ll also hear from a patient who has benefitted from the drug.

Get Email Updates:

Get updated automatically when new content about Melanoma has been posted.
Privacy Policy
EXPERTS & GUESTS:
Kim Margolin,  M.D. Kim Margolin, M.D.
Professor, University of Washington, Seattle Cancer Care Alliance
Dr. Margolin’s clinical efforts are in the treatment of melanoma, kidney cancer and germ cell cancer, and she is particularly interested in clinical trials that provide the newest investigational therapies for her patients. Melanoma and kidney cancer are often treated with immunotherapy, including vaccines, cytokines and immune-cell infusions. Germ cell cancer can be treated effectively with high-dose chemotherapy and autologous... more >

David Byrd,  M.D. David Byrd, M.D.
Surgical Oncologist, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance
Dr. Byrd serves as a General Surgery Specialist and Associate Professor of Surgery at the University of Washington Medical Center, as well as Director of the Melanoma Center. He specializes in surgery, surgery oncology and hepatology. Dr. Byrd received his medical degree from Tulane University and completed residency training at the University of Washington. more >

Kathy Sparks Kathy Sparks,
Melanoma Survivor
Kathy Sparks of Issaquah, Washington, grew up in Florida with fair skin and recalls many sunburns over the years.  She was diagnosed with melanoma in 2005. Kathy was referred to the SCCA for treatment.  Over the years she has endured many surgeries and treatments and, at one point, after melanoma was discovered in her breast during a mammogram, she was... more >

TRANSCRIPT:

RELATED LINKS: